Phyrago Tablet
Product Images NDC 70709-151

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Phyrago (NDC 70709-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Untitled)

FDA Label Image

Carton-100 (Carton 100)

This text is a label for PHYRAGO tablets containing dasatinib, a hazardous drug that should not be crushed, cut, or chewed, but swallowed whole. Each tablet has 100 mg of dasatinib. It provides information on dosage, storage conditions (20°C to 25°C) and manufacturer details for Cycle Pharmaceuticals Ltd in the UK. The NDC number for the tablets is 70709-155-10.*

FDA Label Image

Carton-140 (Carton 140)

The text provides information about a medication called PHYRAGO™ (dasatinib) in tablet form. It includes instructions to not use the product if the inner seal of the bottle is broken or missing, storage temperature recommendations, a warning about it being a hazardous drug, and directions to swallow the tablets whole without crushing, cutting, or chewing them. The tablets are packaged in a bottle containing 30 tablets. The manufacturer is Cycle Pharmaceuticals Ltd based in Cambridy.*

FDA Label Image

Core-20 (Carton 20)

FDA Label Image

Carton-50 (Carton 50)

PHYRAGO™ is a hazardous drug containing dasatinib that comes in tablet form. It is essential not to crush, cut, or chew the tablets and to swallow them whole. Each tablet contains 50 mg of dasatinib. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). The prescription information should be consulted for proper dosage guidance. Manufactured by Cycle Pharmaceuticals Ltd in the UK.*

FDA Label Image

Carton-70 (Carton 70)

This is a description for PHYRAGO™ (dasatinib) Tablets. There are 60 tablets in each bottle with the NDC number 70709-153-70. The dosage information is available in the prescribing information. It is important not to use if the inner seal of the bottle is broken or missing. These tablets are classified as a Hazardous Drug. Instructions state not to crush or chew tablets; they should be swallowed whole. The manufacturer of PHYRAGO™ is Cyle Pharmaceuticals Ltd, located in Cambridge, UK.*

FDA Label Image

Carton-80 (Carton 80)

This text contains information about a medication labeled as "PHYRAGO" with the active ingredient dasatinib. Each tablet contains 80 mg of dasatinib. It is advised to store the medication at a temperature between 20°C to 25°C (68°F to 77°F). The text mentions a warning that it is a hazardous drug and should not be crushed, cut, or chewed; tablets should be swallowed whole. It also gives information regarding the dosage and prescribing details. The text includes a unique identification code, "A000231," and mentions a specific number of tablets in the pack.*

FDA Label Image

Label-100 (Label 100)

FDA Label Image

Label-140 (Label 140)

FDA Label Image

Label-20 (Label 20)

This is a description of a pharmaceutical product with the name "PHYSIOLOGO™". It includes important instructions for use, such as swallowing the tablets whole and not crushing, cutting, or chewing them. The product comes in a package containing 60 tablets, and it appears to be related to a hazardous drug called dasatinib. Additionally, there are numbers and abbreviations that may refer to specific dosages or medical instructions.*

FDA Label Image

Label-50 (Label 50)

FDA Label Image

Label-70 (Label 70)

FDA Label Image

Label-80 (Label 80)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.